Allogeneic Hematopoietic Cell Transplantation Is Critical to Maintain Remissions after CD19-CAR T-Cell Therapy for Pediatric ALL: A Single Center Experience
Aimee C. Talleur(St. Jude Children's Research Hospital), Stephen Gottschalk(St. Jude Children's Research Hospital), Brandon M. Triplett(St. Jude Children's Research Hospital), Terrence L. Geiger(St. Jude Children's Research Hospital), Timothy Lockey(St. Jude Children's Research Hospital), Michael M. Meagher(St. Jude Children's Research Hospital), Ching‐Hon Pui(St. Jude Children's Research Hospital), Salem Akel(St. Jude Children's Research Hospital), Mireya Paulina Velasquez(St. Jude Children's Research Hospital), Ashok Srinivasan(St. Jude Children's Research Hospital), Ewelina Mamcarz(National Institutes of Health), Alisha Gaboriault(St. Jude Children's Research Hospital), Sheng Zhou(St. Jude Children's Research Hospital), Akshay Sharma(St. Jude Children's Research Hospital), Guolian Kang(St. Jude Children's Research Hospital), Hiroto Inaba(St. Jude Children's Research Hospital), Ali Suliman(St. Jude Children's Research Hospital), Cheng Cheng(Jilin University), Ying Li(Chinese Academy of Sciences), Wenting Zheng(Fujian University of Technology), Pam Young(Christ Hospital), Amr Qudeimat(St. Jude Children's Research Hospital), Renee Madden(St. Jude Children's Research Hospital), Seth E. Karol(St. Jude Children's Research Hospital)
Cited by 3
Related Papers
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data
|Blood|2022|2.8k
Treatment of Acute Lymphoblastic Leukemia
|New England Journal of Medicine|2006|2k
Classification, subtype discovery, and prediction of outcome in pediatric acute lymphoblastic leukemia by gene expression profiling
|Cancer Cell|2002|1.9k
Acute lymphoblastic leukaemia
|The Lancet|2008|1.6k